Elevated serum level of interleukin-32α in the patients with myasthenia gravis

Journal of Neurology

Volumn 258, Issue 10, 2011, Pages 1865-1870

  Na, Sang Jun ^a,b   So, Seon Hwa ^a   Lee, Kee Ook ^a,b   Choi, Young Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

Author keywords

Autoimmune disorder; Interleukin 32 (IL 32 ); Myasthenia gravis (MG); Natural killer cell (NK)

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; INTERLEUKIN 32; INTERLEUKIN 32 ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; NATURAL KILLER CELL; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

ADULT; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; YOUNG ADULT;

EID: 80054741469     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6036-7     Document Type: Article

References (20)

1. FD Shi HB Wang H Li S Hong M Taniguchi H Link L Van Kaer HG Ljunggren 2000 Natural killer cells determine the outcome of B cell-mediated autoimmunity Nat Immunol 1 245 251 10973283 10.1038/79792 1:CAS:528:DC%2BD3cXmsVyiurg%3D
2. BM Conti-Fine M Milani HJ Kaminski 2006 Myasthenia gravis: past, present and future J Clin Invest 116 2843 2854 17080188 10.1172/JCI29894 1:CAS:528:DC%2BD28XhtFyrsLnE (Pubitemid 44684466)
3. CA Dahl RP Schall HL He JS Cairns 1992 Identification of a novel gene expressed inactivated natural killer cells and T cells J Immunol 148 597 603 1729377 1:CAS:528:DyaK3sXjslChuw%3D%3D
4. SH Kim SY Han T Azam DY Yoon CA Dinarello 2005 Interleukin-32: a cytokine and inducer of TNF alpha Immunity 22 131 142 15664165 1:CAS:528: DC%2BD2MXht1Cgsbs%3D (Pubitemid 40143457)
5. CA Dinarello SH Kim 2006 IL-32, a novel cytokine with a possible role in disease Ann Rheum Dis 65 Suppl 3 iii61 iii64 17038476 10.1136/ard.2006.058511 (Pubitemid 44629106)
6. MF Nold CA Nold-Petry GB Pott JA Zepp MT Saavedra SH Kim CA Dinarello 2008 Endogenous IL-32 controls cytokine and HIV-1 production J Immunol 181 557 565 18566422 1:CAS:528:DC%2BD1cXnsVGisLc%3D
7. LA Joosten MG Netea SH Kim DY Yoon B Oppers-Walgreen TR Radstake P Barrera FA van de Loo CA Dinarello WB van den Berg 2006 IL-32, a proinflammatory cytokine in rheumatoid arthritis Proc Natl Acad Sci USA 103 3298 3303 16492735 10.1073/pnas.0511233103 1:CAS:528:DC%2BD28XksF2ktLY%3D (Pubitemid 43346464)
8. M Shioya A Nishida Y Yagi A Ogawa T Tsujikawa S Kim-Mitsuyama A Takayanagi N Shimizu Y Fujiyama A Andoh 2007 Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease Clin Exp Immunol 149 480 486 17590175 10.1111/j.1365-2249.2007.03439.x 1:CAS:528:DC%2BD2sXhtFSlurzF (Pubitemid 47256156)
9. A Jaretzki 3rd RJ Barohn RM Ernstoff HJ Kaminski JC Keesey AS Penn DB Sanders 2000 Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 16 23 10891897
10. DB Drachman 1994 Myasthenia gravis N Engl J Med 330 1797 1810 8190158 10.1056/NEJM199406233302507 1:STN:280:DyaK2c3kslCrtQ%3D%3D
11. P Conti P Youinou TC Theoharides 2007 Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32) Autoimmun Rev 6 131 137 17289547 10.1016/j.autrev.2006.08.015 1:CAS:528:DC%2BD2sXjvV2ktbg%3D (Pubitemid 46188721)
12. MG Netea T Azam G Ferwerda SE Girardin M Walsh JS Park E Abraham JM Kim DY Yoon CA Dinarello SH Kim 2005 IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism Proc Natl Acad Sci USA 102 16309 16314 16260731 10.1073/pnas.0508237102 1:CAS:528:DC%2BD2MXht1CgurrJ (Pubitemid 41688910)
13. S Jander G Stoll 2002 Increased serum levels of the interferon-gamma- inducing cytokine interleukin-18 in myasthenia gravis Neurology 59 287 289 12136075 (Pubitemid 34779195)
14. R Furlan G Martino F Galbiati PL Poliani S Smiroldo A Bergami G Desina G Comi R Flavell MS Su L Adorini 1999 Caspase-1 regulates the inflammatory process leading to autoimmune demyelination J Immunol 163 2403 2409 10452974 1:CAS:528:DyaK1MXls1Krs7o%3D (Pubitemid 29399158)
15. GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature 423 356 361 12748655 10.1038/nature01661 1:CAS:528:DC%2BD3sXjs1ynu7c%3D (Pubitemid 40852711)
16. HM van Dullemen SJ van Deventer DW Hommes HA Bijl J Jansen GN Tytgat J Woody 1995 Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 129 135 7797011 10.1016/0016-5085(95)90277-5
17. CL Leonardi JL Powers RT Matheson BS Goffe R Zitnik A Wang AB Gottlieb Etanercept Psoriasis Study Group 2003 Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2014 2022 14627786 10.1056/NEJMoa030409 1:CAS:528:DC%2BD3sXptFKmtrg%3D (Pubitemid 37448924)
18. RS Duan HB Wang JS Yang B Scallon H Link BG Xiao 2002 Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis J Autoimmun 19 169 174 12473237 10.1006/jaut.2002.0618 (Pubitemid 36262931)
19. C Deng E Goluszko E Tüzün H Yang P Christadoss 2002 Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production J Immunol 169 1077 1083 12097416 1:CAS:528:DC%2BD38XlsVWjsb4%3D (Pubitemid 34753468)
20. DF Jelinek PE Lipsky 1987 Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1 J Immunol 139 2970 2976 3117883 1:CAS:528:DyaL1cXitVaqtQ%3D%3D (Pubitemid 17157466)